# Gandeeva Therapeutics: Research, Vancouver, Canada

> Gandeeva Therapeutics: Gandeeva Therapeutics is a precision biotechnology company based in Burnaby, British Columbia, Canada, founded in 2021.

Source: https://millionrounds.com/startup/gandeeva-therapeutics (Millionrounds; every figure on the page links to its filing or article)

Canada · [Research startup](https://millionrounds.com/companies)

# Gandeeva Therapeutics

Gandeeva Therapeutics is a precision biotechnology company based in Burnaby, British Columbia, Canada, founded in 2021.

Funding reported Last round: Series A

Research Vancouver, Canada

Company summary

- **Founded:** 2021 5 years old
- **Team:** 24 11 to 50 people
- **Funding reported:** 40M as listed, currency not stated
- **Last round:** Series A Jan 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Gandeeva Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Gandeeva Therapeutics

Gandeeva Therapeutics is a precision biotechnology company based in Burnaby, British Columbia, Canada, founded in 2021.

The company focuses on advancing drug discovery by targeting transient and challenging protein interactions. With a successful $40 million Series A funding round in January 2022, Gandeeva aims to develop innovative molecular therapeutics, including molecular glues and allosteric inhibitors, primarily for oncology applications. Gandeeva utilizes a proprietary platform that integrates artificial intelligence, machine learning, structural biology, and cryogenic electron microscopy (cryo-EM) to enhance drug discovery. Their technology includes three main modules: SPOTLIGHTTM for target prediction, HYPERFOCUSTM for atomic-resolution imaging, and CRYO-CADDTM for lead optimization. The company is actively developing a preclinical oncology pipeline with four drug candidates focused on modulating key protein-protein interactions that drive cancer progression. Gandeeva collaborates with major pharmaceutical firms, including Moderna and Amgen Ventures, to leverage its technology in therapeutic development.

## What company datasets say Gandeeva Therapeutics raised

Funding, as reported

Reported in all **40M** in the source's currency

Rounds **1**

Last round **Series A**

Last round size **40M**

Last round date **Jan 2022**

Investors listed **6**

## Founders and team

From Gandeeva Therapeutics's own website: 1 founder, 6 on the team.

**Sriram Subramaniam** Founder & CEO

- **Janet George** Executive Vice President of Artificial Intelligence of Mastercard
- **David Karp** Chief Financial Officer
- **Robert Sikorski** Chief Medical Officer Consultant
- **Jay Galeota** Director
- **Shaq Vayda** Director
- **Tom Ceska** Senior Director, Structural Biology and Cryo-EM Operations

## On 2 portfolio pages

Investors who name them

- [Obvious Ventures](https://millionrounds.com/fund/obvious-ventures)
- [Air Street Capital](https://millionrounds.com/fund/air-street-capital)

Each firm lists Gandeeva Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care protein surface mapping cryogenic electron microscopy biotechnology research structure-based drug design ai-enabled structural prediction structural biology medical research information technology & services protein surface structure computational drug design lead optimization hospital & health care medical protein-protein interactions target validation

Built with from their website

Google Tag Manager WordPress.org Google Cloud Font Awesome Elementor Viewport Meta Site Kit Varnish DoubleClick for Publishers Hello Elementor

+8 more

Google Cloud Hosting Complianz Priority Hints CAPTCHA imagesLoaded Microsoft Exchange Perfmatters MySQL

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834, 8731
- **Region:** British Columbia
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/gandeeva-therapeutics)

## Research in Canada

Startups like it

- [**Altis Labs** Toronto · founded 2019 *Raised*](https://millionrounds.com/company/altis-labs)
- [**Sitka Biopharma** Vancouver · founded 2013 *Raised*](https://millionrounds.com/company/sitka-biopharma)
- [**ServiceNow AI Research** Montreal · founded 2016](https://millionrounds.com/startup/servicenow-ai-research)
- [**DalCor Pharmaceuticals** Montreal · founded 2015](https://millionrounds.com/startup/dalcor-pharmaceuticals)
- [**Notch Therapeutics** Vancouver · founded 2018](https://millionrounds.com/startup/notch-therapeutics)
- [**chemical.ai** Toronto · founded 2018](https://millionrounds.com/startup/chemical-ai)
- [**Congruence Therapeutics** Montreal · founded 2021](https://millionrounds.com/startup/congruence-therapeutics)
- [**Zucara Therapeutics Inc.** Toronto · founded 2015](https://millionrounds.com/startup/zucara-therapeutics-inc)

## Is this your company?

Add your raise, your deck and your story, and put Gandeeva Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)